TY - JOUR
T1 - Visual impairment and medication safety: a protocol for a scoping review
AU - Giles, Sally J
AU - Panagioti, Maria
AU - Riste, Lisa
AU - Cheraghi-Sohi, Sudeh
AU - Lewis, Penny
AU - Adeyemi, Isabel
AU - Davies, Karen
AU - Morris, Rebecca
AU - Phipps, Denham
AU - Dickinson, Chris
AU - Ashcroft, Darren
AU - Sanders, Caroline
N1 - Funding Information:
This research was funded by the National Institute for Health Research through the Greater Manchester Patient Safety Translational Research Centre (NIHR Greater Manchester PSTRC). The views expressed are those of the authors and not necessarily those of the NIHR or Department of Health and Social Care.
Publisher Copyright:
© 2021, The Author(s).
PY - 2021/12/1
Y1 - 2021/12/1
N2 - BACKGROUND: The number of individuals with a visual impairment in the UK was estimated a few years ago to be around 1.8 million. People can be visually impaired from birth, childhood, early adulthood or later in life. Those with visual impairment are subject to health inequities and increased risk for patient safety incidents in comparison to the general population. They are also known to be at an increased risk of experiencing medication errors compared to those without visual impairment. In view of this, this review aims to understand the issues of medication safety for VI people.METHODS/DESIGN: Four electronic bibliographic databases will be searched: MEDLINE, Embase, PsycInfo and CINAHL. Our search strategy will include search combinations of two key blocks of terms. Studies will not be excluded based on design. Included studies will be empirical studies. They will include studies that relate to both medication safety and visual impairment. Two reviewers (SG and LR) will screen all the titles and abstracts. SG, LR, RM, SCS and PL will perform study selection and data extraction using standard forms. Disagreements will be resolved through discussion or third party adjudication. Data to be collected will include study characteristics (year, objective, research method, setting, country), participant characteristics (number, age, gender, diagnoses), medication safety incident type and characteristics.DISCUSSION: The review will summarise the literature relating to medication safety and visual impairment.
AB - BACKGROUND: The number of individuals with a visual impairment in the UK was estimated a few years ago to be around 1.8 million. People can be visually impaired from birth, childhood, early adulthood or later in life. Those with visual impairment are subject to health inequities and increased risk for patient safety incidents in comparison to the general population. They are also known to be at an increased risk of experiencing medication errors compared to those without visual impairment. In view of this, this review aims to understand the issues of medication safety for VI people.METHODS/DESIGN: Four electronic bibliographic databases will be searched: MEDLINE, Embase, PsycInfo and CINAHL. Our search strategy will include search combinations of two key blocks of terms. Studies will not be excluded based on design. Included studies will be empirical studies. They will include studies that relate to both medication safety and visual impairment. Two reviewers (SG and LR) will screen all the titles and abstracts. SG, LR, RM, SCS and PL will perform study selection and data extraction using standard forms. Disagreements will be resolved through discussion or third party adjudication. Data to be collected will include study characteristics (year, objective, research method, setting, country), participant characteristics (number, age, gender, diagnoses), medication safety incident type and characteristics.DISCUSSION: The review will summarise the literature relating to medication safety and visual impairment.
KW - Medication safety
KW - Visual impairment
U2 - 10.1186/s13643-021-01800-8
DO - 10.1186/s13643-021-01800-8
M3 - Article
C2 - 34526103
SN - 2046-4053
VL - 10
JO - Systematic Reviews
JF - Systematic Reviews
IS - 1
M1 - 248
ER -
